Jagsonpal Pharmaceuticals Live BSE/NSE | Jagsonpal Pharmaceuticals Fundamenta data | Jagsonpal Pharmaceuticals Balance sheet | Jagsonpal Pharmaceuticals Quarterly Results | Jagsonpal Pharmaceuticals Profit & Loss | Jagsonpal Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

200.81
19.37
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

167.40
0.65%
1.83

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.15
2.02
7.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-5.19
-6.30
-

PAT CAGR (%)

10 Years
5 Years
3 Years

0.92
19.35
-

P:E (Median)

8 Years
5 Years
3 Years

15.35
9.77
7.78

P:BV (Average)

8 Years
5 Years
3 Years

1.00
1.00
1.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

275.24
435.45
8.62

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 56.35 41.81 34.78% 31.65 45.23 -30.02% 29.52 38.40 -23.12% 42.01 41.89 0.29%
Expenses 51.52 39.30 31.09% 29.00 43.00 -32.56% 28.29 34.99 -19.15% 39.45 39.69 -0.60%
EBITDA 4.83 2.51 92.43% 2.65 2.24 18.30% 1.22 3.41 -64.22% 2.56 2.20 16.36%
EBIDTM 8.58% 6.00% 8.37% 4.95% 4.14% 8.88% 6.10% 5.25%
Other Income 0.41 0.44 -6.82% 0.78 0.67 16.42% 0.76 0.88 -13.64% 0.65 0.28 132.14%
Interest 0.12 0.15 -20.00% 0.13 0.12 8.33% 0.15 0.27 -44.44% 0.10 0.10 0.00%
Depreciation 0.28 0.27 3.70% 0.28 0.29 -3.45% 0.32 0.28 14.29% 0.26 0.23 13.04%
PBT 4.85 2.54 90.94% 3.03 2.50 21.20% 1.52 3.74 -59.36% 2.85 2.14 33.18%
Tax 0.85 0.51 66.67% 0.51 0.50 2.00% -0.03 0.76 - 0.57 0.40 42.50%
PAT 4.01 2.03 97.54% 2.52 2.00 26.00% 1.55 2.98 -47.99% 2.28 1.74 31.03%
PATM 7.11% 4.86% 7.96% 4.43% 5.26% 7.75% 5.43% 4.16%
EPS 1.53 0.77 98.70% 0.96 0.76 26.32% 0.59 1.14 -48.25% 0.87 0.67 29.85%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 159.53 158.57 166.83 126.53 143.87 143.49 138.15 143.85 166.46 176.51 160.96 Net Sales Growth -4.66% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% -13.58% -5.69% 9.66% Cost Of Goods Sold 62.24 56.19 72.85 61.11 58.95 59.13 68.68 64.71 86.16 84.54 83.00 Gross Profit 97.29 102.38 93.98 65.42 84.92 84.36 69.47 79.14 80.30 91.97 77.95 GP Margin 60.98% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% 48.24% 52.10% 48.43% Total Expenditure 148.26 150.04 157.49 137.64 138.10 131.68 129.42 133.17 156.41 159.90 146.42 Power & Fuel Cost - 0.64 1.41 1.00 2.12 2.26 1.77 2.23 2.55 2.52 2.05 % Of Sales - 0.40% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% 1.53% 1.43% 1.27% Employee Cost - 50.37 46.61 41.88 40.95 37.84 32.11 37.83 37.25 36.51 32.22 % Of Sales - 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% 22.38% 20.68% 20.02% Manufacturing Exp. - 0.45 0.73 0.96 1.34 1.70 1.01 1.57 2.01 1.04 1.51 % Of Sales - 0.28% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% 1.21% 0.59% 0.94% General & Admin Exp. - 20.50 19.03 16.31 16.44 13.61 9.64 8.55 8.87 8.87 7.52 % Of Sales - 12.93% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% 5.33% 5.03% 4.67% Selling & Distn. Exp. - 17.84 13.20 11.25 13.74 12.96 11.53 14.36 15.45 20.28 14.98 % Of Sales - 11.25% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% 9.28% 11.49% 9.31% Miscellaneous Exp. - 4.04 3.66 5.14 4.56 4.19 4.67 3.92 4.11 6.14 14.98 % Of Sales - 2.55% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% 2.47% 3.48% 3.19% EBITDA 11.26 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 10.05 16.61 14.54 EBITDA Margin 7.06% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% 6.04% 9.41% 9.03% Other Income 2.60 2.53 1.43 0.46 0.47 0.66 0.11 0.06 0.32 0.37 0.26 Interest 0.50 0.51 0.75 0.66 2.64 5.30 4.46 5.38 5.13 4.36 3.32 Depreciation 1.14 1.13 1.02 0.32 1.99 3.09 2.71 2.83 2.71 2.54 2.20 PBT 12.25 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 2.54 10.09 9.27 Tax 1.90 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 0.70 2.63 2.09 Tax Rate 15.51% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% 27.56% 26.07% 22.55% PAT 10.36 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 7.18 PAT before Minority Interest 10.36 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 1.83 7.46 7.18 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.49% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% 1.10% 4.23% 4.46% PAT Growth 18.40% 9.00% 162.51% -197.39% 264.92% 177.78% -44.81% 15.85% -75.47% 3.90% Unadjusted EPS 3.95 3.00 2.76 -4.41 4.53 1.24 0.45 0.81 0.70 2.85 2.74

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

159.53

158.57

166.83

126.53

143.87

143.49

138.15

143.85

166.46

176.51

160.96

Net Sales Growth

-4.66%

-4.95%

31.85%

-12.05%

0.26%

3.87%

-3.96%

-13.58%

-5.69%

9.66%

Cost Of Goods Sold

62.24

56.19

72.85

61.11

58.95

59.13

68.68

64.71

86.16

84.54

83.00

Gross Profit

97.29

102.38

93.98

65.42

84.92

84.36

69.47

79.14

80.30

91.97

77.95

GP Margin

60.98%

64.56%

56.33%

51.70%

59.03%

58.79%

50.29%

55.02%

48.24%

52.10%

48.43%

Total Expenditure

148.26

150.04

157.49

137.64

138.10

131.68

129.42

133.17

156.41

159.90

146.42

Power & Fuel Cost

0.64

1.41

1.00

2.12

2.26

1.77

2.23

2.55

2.52

2.05

% Of Sales

0.40%

0.85%

0.79%

1.47%

1.58%

1.28%

1.55%

1.53%

1.43%

1.27%

Employee Cost

50.37

46.61

41.88

40.95

37.84

32.11

37.83

37.25

36.51

32.22

% Of Sales

31.77%

27.94%

33.10%

28.46%

26.37%

23.24%

26.30%

22.38%

20.68%

20.02%

Manufacturing Exp.

0.45

0.73

0.96

1.34

1.70

1.01

1.57

2.01

1.04

1.51

% Of Sales

0.28%

0.44%

0.76%

0.93%

1.18%

0.73%

1.09%

1.21%

0.59%

0.94%

General & Admin Exp.

20.50

19.03

16.31

16.44

13.61

9.64

8.55

8.87

7.52

% Of Sales

12.93%

11.41%

12.89%

11.43%

9.48%

6.98%

5.94%

5.33%

5.03%

4.67%

Selling & Distn. Exp.

17.84

13.20

11.25

13.74

12.96

11.53

14.36

15.45

20.28

14.98

% Of Sales

11.25%

7.91%

8.89%

9.55%

9.03%

8.35%

9.98%

9.28%

11.49%

9.31%

Miscellaneous Exp.

4.04

3.66

5.14

4.56

4.19

4.67

3.92

4.11

6.14

14.98

% Of Sales

2.55%

2.19%

4.06%

3.17%

2.92%

3.38%

2.73%

2.47%

3.48%

3.19%

EBITDA

11.26

8.53

9.34

-11.11

5.77

11.81

8.73

10.68

10.05

16.61

14.54

EBITDA Margin

7.06%

5.38%

5.60%

-8.78%

4.01%

8.23%

6.32%

7.42%

6.04%

9.41%

9.03%

Other Income

2.60

2.53

1.43

0.46

0.47

0.66

0.11

0.06

0.32

0.37

0.26

Interest

0.50

0.51

0.75

0.66

2.64

5.30

4.46

5.38

5.13

4.36

3.32

Depreciation

1.14

1.13

1.02

0.32

1.99

3.09

2.71

2.83

2.71

2.54

2.20

PBT

12.25

9.41

9.00

-11.63

1.60

4.08

1.67

2.53

2.54

10.09

9.27

Tax

1.90

1.54

1.79

-0.08

2.53

0.82

0.50

0.41

0.70

2.63

2.09

Tax Rate

15.51%

16.37%

19.89%

0.69%

17.57%

20.10%

29.94%

16.21%

27.56%

26.07%

22.55%

PAT

10.36

7.87

7.22

-11.55

11.86

3.25

1.17

2.12

1.83

7.46

7.18

PAT before Minority Interest

10.36

7.87

7.22

-11.55

11.86

3.25

1.17

2.12

1.83

7.46

7.18

Minority Interest

0.00

PAT Margin

6.49%

4.96%

4.33%

-9.13%

8.24%

2.26%

0.85%

1.47%

1.10%

4.23%

4.46%

PAT Growth

18.40%

9.00%

162.51%

-197.39%

264.92%

177.78%

-44.81%

15.85%

-75.47%

3.90%

Unadjusted EPS

3.95

3.00

2.76

-4.41

4.53

1.24

0.45

0.81

0.70

2.85

2.74

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 111.03 104.47 98.05 109.91 98.36 95.43 98.59 98.37 98.47 92.91 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 97.93 91.37 84.95 96.81 85.27 82.33 85.49 85.27 85.37 79.81 Non-Current Liabilities 3.09 3.12 3.19 3.26 3.61 3.60 4.08 4.50 4.25 3.63 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.32 0.27 0.26 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 32.83 28.19 28.58 29.44 57.31 55.19 53.58 50.13 53.38 40.17 Trade Payables 11.71 11.86 9.09 8.98 9.73 7.87 5.08 6.51 8.14 4.61 Other Current Liabilities 8.16 5.60 6.10 7.12 6.61 6.24 5.48 3.99 4.79 3.42 Short Term Borrowings 4.66 3.79 8.30 7.93 38.49 39.31 35.96 33.09 34.62 28.33 Short Term Provisions 8.30 6.95 5.09 5.41 2.48 1.77 7.06 6.55 5.83 3.81 Total Liabilities 146.95 135.78 129.82 142.61 159.28 154.22 156.25 153.00 156.10 136.71 Net Block 22.09 21.64 21.32 21.59 51.61 51.96 56.41 58.35 59.15 57.68 Gross Block 55.83 55.00 53.66 52.88 90.35 87.61 87.01 85.75 83.44 79.06 Accumulated Depreciation 33.74 33.36 32.34 31.28 38.74 35.65 30.60 27.41 24.29 21.38 Non Current Assets 52.04 38.23 35.20 32.50 58.32 58.43 64.94 66.46 65.17 60.87 Capital Work in Progress 4.25 3.95 3.04 0.00 0.00 0.00 2.35 2.33 0.93 0.00 Non Current Investment 11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 14.32 12.63 10.84 10.90 6.71 6.47 6.19 5.78 5.09 3.19 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 94.91 97.56 94.61 110.11 100.96 95.79 91.31 86.54 90.93 75.85 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 29.32 32.69 51.43 47.62 39.84 33.06 30.59 30.07 35.22 22.55 Sundry Debtors 21.45 20.75 25.15 39.41 41.69 44.89 45.22 42.20 42.31 42.98 Cash & Bank 38.07 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 Other Current Assets 6.06 0.94 0.24 0.23 3.90 2.83 2.90 3.93 3.53 2.98 Short Term Loans & Adv. 5.17 4.64 3.27 2.80 3.90 2.83 2.90 3.93 3.53 2.98 Net Current Assets 62.08 69.37 66.03 80.68 43.65 40.60 37.73 36.41 37.55 35.67 Total Assets 146.95 135.79 129.81 142.61 159.28 154.22 156.25 153.00 156.10 136.72

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

111.03

104.47

98.05

109.91

98.36

95.43

98.59

98.37

98.47

92.91

Share Capital

13.10

Total Reserves

97.93

91.37

84.95

96.81

85.27

82.33

85.49

85.27

85.37

79.81

Non-Current Liabilities

3.09

3.12

3.19

3.26

3.61

3.60

4.08

4.50

4.25

3.63

Secured Loans

0.00

Unsecured Loans

0.00

0.32

0.27

0.26

Long Term Provisions

0.00

Current Liabilities

32.83

28.19

28.58

29.44

57.31

55.19

53.58

50.13

53.38

40.17

Trade Payables

11.71

11.86

9.09

8.98

9.73

7.87

5.08

6.51

8.14

4.61

Other Current Liabilities

8.16

5.60

6.10

7.12

6.61

6.24

5.48

3.99

4.79

3.42

Short Term Borrowings

4.66

3.79

8.30

7.93

38.49

39.31

35.96

33.09

34.62

28.33

Short Term Provisions

8.30

6.95

5.09

5.41

2.48

1.77

7.06

6.55

5.83

3.81

Total Liabilities

146.95

135.78

129.82

142.61

159.28

154.22

156.25

153.00

156.10

136.71

Net Block

22.09

21.64

21.32

21.59

51.61

51.96

56.41

58.35

59.15

57.68

Gross Block

55.83

55.00

53.66

52.88

90.35

87.61

87.01

85.75

83.44

79.06

Accumulated Depreciation

33.74

33.36

32.34

31.28

38.74

35.65

30.60

27.41

24.29

21.38

Non Current Assets

52.04

38.23

35.20

32.50

58.32

58.43

64.94

66.46

65.17

60.87

Capital Work in Progress

4.25

3.95

3.04

0.00

2.35

2.33

0.93

0.00

Non Current Investment

11.39

0.00

Long Term Loans & Adv.

14.32

12.63

10.84

10.90

6.71

6.47

6.19

5.78

5.09

3.19

Other Non Current Assets

0.00

Current Assets

94.91

97.56

94.61

110.11

100.96

95.79

91.31

86.54

90.93

75.85

Current Investments

0.00

Inventories

29.32

32.69

51.43

47.62

39.84

33.06

30.59

30.07

35.22

22.55

Sundry Debtors

21.45

20.75

25.15

39.41

41.69

44.89

45.22

42.20

42.31

42.98

Cash & Bank

38.07

38.53

14.51

20.06

15.53

15.02

12.60

10.34

9.88

7.33

Other Current Assets

6.06

0.94

0.24

0.23

3.90

2.83

2.90

3.93

3.53

2.98

Short Term Loans & Adv.

5.17

4.64

3.27

2.80

3.90

2.83

2.90

3.93

3.53

2.98

Net Current Assets

62.08

69.37

66.03

80.68

43.65

40.60

37.73

36.41

37.55

35.67

Total Assets

146.95

135.79

129.81

142.61

159.28

154.22

156.25

153.00

156.10

136.72

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 11.25 30.90 -1.58 -3.24 9.04 4.30 7.52 12.05 7.08 4.97 PBT 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 2.54 10.09 9.27 Adjustment -0.85 0.33 1.26 -8.63 7.73 7.05 8.15 7.52 6.52 5.26 Changes in Working Capital 4.25 19.71 8.79 -6.13 -1.96 -4.09 -2.65 2.50 -7.51 -7.47 Cash after chg. in Working capital 12.82 29.05 -1.58 -0.36 9.85 4.63 8.02 12.56 9.10 7.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.57 1.85 0.00 -2.88 -0.82 -0.33 -0.51 -0.51 -2.02 -2.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -10.76 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 -3.39 -4.94 -6.75 Net Fixed Assets -1.13 -2.25 -3.82 37.47 -2.74 1.75 -1.28 -3.71 -5.31 -7.01 Net Investments -11.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 1.76 1.42 0.45 3.82 0.65 -2.21 0.07 0.32 0.37 0.26 Cash from Financing Activity -0.94 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 -8.19 0.41 3.47 Net Cash Inflow / Outflow -0.46 24.02 -5.55 4.53 0.52 2.41 2.26 0.46 2.56 1.69 Opening Cash & Equivalents 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33 5.63 Closing Cash & Equivalent 38.07 38.53 14.51 20.06 15.53 15.02 12.60 10.34 9.88 7.33

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

11.25

30.90

-1.58

-3.24

9.04

4.30

7.52

12.05

7.08

4.97

PBT

9.41

9.00

-11.63

14.40

4.08

1.67

2.53

2.54

10.09

9.27

Adjustment

-0.85

0.33

1.26

-8.63

7.73

7.05

8.15

7.52

6.52

5.26

Changes in Working Capital

4.25

19.71

8.79

-6.13

-1.96

-4.09

-2.65

2.50

-7.51

-7.47

Cash after chg. in Working capital

12.82

29.05

-1.58

-0.36

9.85

4.63

8.02

12.56

9.10

7.06

Interest Paid

0.00

Tax Paid

-1.57

1.85

0.00

-2.88

-0.82

-0.33

-0.51

-2.02

-2.09

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-10.76

-0.83

-3.37

41.29

-2.09

-0.46

-1.21

-3.39

-4.94

-6.75

Net Fixed Assets

-1.13

-2.25

-3.82

37.47

-2.74

1.75

-1.28

-3.71

-5.31

-7.01

Net Investments

-11.39

0.00

Others

1.76

1.42

0.45

3.82

0.65

-2.21

0.07

0.32

0.37

0.26

Cash from Financing Activity

-0.94

-6.05

-0.60

-33.52

-6.43

-1.42

-4.04

-8.19

0.41

3.47

Net Cash Inflow / Outflow

-0.46

24.02

-5.55

4.53

0.52

2.41

2.26

0.46

2.56

1.69

Opening Cash & Equivalents

38.53

14.51

20.06

15.53

15.02

12.60

10.34

9.88

7.33

5.63

Closing Cash & Equivalent

38.07

38.53

14.51

20.06

15.53

15.02

12.60

10.34

9.88

7.33

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 39.39 36.89 34.43 38.96 34.55 33.43 32.86 32.63 32.52 30.25 ROA 5.57% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% 1.19% 5.09% 5.52% ROE 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% 2.15% 9.07% 9.39% ROCE 9.53% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% 6.42% 12.68% 12.48% Fixed Asset Turnover 2.86 3.07 2.38 2.03 1.62 1.59 1.68 2.01 2.22 2.19 Receivable days 48.57 50.22 93.07 102.03 109.58 118.23 109.72 90.52 86.16 89.25 Inventory Days 71.38 92.03 142.78 110.02 92.27 83.52 76.13 69.93 58.36 49.65 Payable days 34.40 31.91 27.07 22.17 21.36 15.26 9.95 12.35 10.51 12.93 Cash Conversion Cycle 85.55 110.33 208.78 189.88 180.49 186.49 175.90 148.10 134.00 125.97 Total Debt/Equity 0.05 0.04 0.09 0.08 0.43 0.45 0.42 0.39 0.41 0.36 Interest Cover 19.31 13.08 -16.69 6.44 1.77 1.37 1.47 1.49 3.32 3.79

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

39.39

36.89

34.43

38.96

34.55

33.43

32.86

32.63

32.52

30.25

ROA

5.57%

5.43%

-8.48%

7.86%

2.08%

0.75%

1.37%

1.19%

5.09%

5.52%

ROE

7.88%

7.72%

-12.01%

12.32%

3.65%

1.35%

2.47%

2.15%

9.07%

9.39%

ROCE

9.53%

9.80%

-10.52%

14.26%

7.32%

4.93%

6.57%

6.42%

12.68%

12.48%

Fixed Asset Turnover

2.86

3.07

2.38

2.03

1.62

1.59

1.68

2.01

2.22

2.19

Receivable days

48.57

50.22

93.07

102.03

109.58

118.23

109.72

90.52

86.16

89.25

Inventory Days

71.38

92.03

142.78

110.02

92.27

83.52

76.13

69.93

58.36

49.65

Payable days

34.40

31.91

27.07

22.17

21.36

15.26

9.95

12.35

10.51

12.93

Cash Conversion Cycle

85.55

110.33

208.78

189.88

180.49

186.49

175.90

148.10

134.00

125.97

Total Debt/Equity

0.05

0.04

0.09

0.08

0.43

0.45

0.42

0.39

0.41

0.36

Interest Cover

19.31

13.08

-16.69

6.44

1.77

1.37

1.47

1.49

3.32

3.79

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 507789 | NSE: JAGSNPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update